Taj Pharmaceuticals – Leading Manufacturer & Exporter of Cinacalcet 60mg Tablets in India
Taj Pharmaceuticals Ltd., a globally recognized Cinacalcet 60mg Tablets Manufacturer based in Vapi, Gujarat, India, is renowned for its commitment to quality, efficacy, and regulatory compliance. As a trusted supplier, exporter, and manufacturer, Taj Pharmaceuticals has solidified its position as a pioneer in the pharmaceutical industry, especially for life-saving medications like Cinacalcet Tablets used in the management of hyperparathyroidism and hypercalcemia.
What is Cinacalcet 60mg?
Cinacalcet 60mg Tablets are a calcimimetic agent that works by decreasing levels of parathyroid hormone (PTH), calcium, and phosphorus in the body. It is most commonly prescribed to patients suffering from secondary hyperparathyroidism associated with chronic kidney disease (CKD) on dialysis, and for treatment of hypercalcemia in patients with parathyroid carcinoma or primary hyperparathyroidism when parathyroidectomy is not possible.
Mechanism of Action of Cinacalcet Tablets
Cinacalcet works by increasing the sensitivity of calcium-sensing receptors on the parathyroid gland to extracellular calcium. This action leads to a reduction in PTH secretion, which consequently lowers serum calcium levels. Through this mechanism, Cinacalcet effectively restores calcium balance in patients with elevated parathyroid hormone levels.
Cinacalcet Tablets – Trusted Formulation by Taj Pharmaceuticals
At Taj Pharmaceuticals, every Cinacalcet Tablet 60mg undergoes rigorous quality checks, ensuring adherence to international manufacturing standards (WHO-GMP and EU-GMP). The production is carried out in state-of-the-art facilities equipped with the latest technological advancements to maintain the purity, potency, and stability of the final product.
Key Features of Cinacalcet 60mg Tablets by Taj Pharmaceuticals
- High Purity API
- Accurate Dosage Strength
- Stable Shelf Life
- Tamper-Proof Packaging
- Affordable Pricing
- Wide Distribution Across PAN India, Africa, Middle East, and LTAM regions
Applications and Indications
Cinacalcet Tablets are indicated for:
- Secondary hyperparathyroidism (sHPT) in patients with CKD on dialysis
- Hypercalcemia in patients with parathyroid carcinoma
- Primary hyperparathyroidism when surgery is not an option
These tablets are instrumental in helping patients manage the symptoms of calcium and phosphate imbalance, which, if left untreated, can lead to serious complications including cardiovascular disease, bone abnormalities, and calcification.
Taj Pharmaceuticals – Cinacalcet Tablets Supplier Across Globe
We are proud to be a global supplier and exporter of Cinacalcet Tablets, offering bulk manufacturing, private labeling, and PCD Pharma Franchise opportunities. Our products are not only distributed throughout India, including Mumbai, Maharashtra, but also exported extensively to Africa, the Middle East, Latin America, and Southeast Asia.
Cinacalcet Tablets Exporter – Regulatory & Compliance Strength
Taj Pharmaceuticals has a dedicated regulatory affairs team to ensure that all documentation for registration and compliance, including CTD dossiers, BE studies, and stability data, are provided to support partners worldwide. We are compliant with WHO-GMP, ISO 9001:2015, and GLP certifications, enabling us to meet both domestic and international pharmaceutical regulations.
PCD Pharma Franchise for Cinacalcet 60mg Tablets
We offer lucrative PCD Pharma Franchise opportunities for Cinacalcet Tablets across India. Our franchise program is ideal for businesses looking to establish or expand their pharmaceutical product line with high-quality, in-demand formulations. With strong marketing support, monopoly rights, and on-time product delivery, our franchise partners achieve rapid market penetration and business growth.
Dosage & Administration
The starting dose of Cinacalcet is typically 30mg once daily, and it can be titrated up to 60mg or higher, depending on patient response and serum calcium/PTH levels. It is advised to take Cinacalcet with food or shortly after a meal to improve absorption.
Important Precautions and Side Effects
- May cause hypocalcemia (low blood calcium levels) – symptoms include muscle spasms, tingling sensations, and seizures.
- Dizziness or drowsiness can occur; patients should avoid operating heavy machinery or driving until they understand how the medication affects them.
- Smoking may alter the effectiveness of Cinacalcet – consult a physician before starting or stopping smoking while on this medication.
Why Choose Taj Pharmaceuticals for Cinacalcet 60mg Tablets?
Taj Pharmaceuticals stands out as the leading manufacturer and exporter of Cinacalcet Tablets due to:
- More than two decades of pharmaceutical expertise
- Dedicated manufacturing units in Vapi, Gujarat
- Customized solutions for global pharmaceutical markets
- Compliance with stringent international quality benchmarks
- Strong logistic and supply chain network for timely deliveries
Cinacalcet 60mg Tablets – Packaging Options
We provide a range of packaging options to suit every client’s needs:
- Blister Packs
- Alu-Alu Packs
- Custom-branded packaging for bulk exports and franchise partners
Cinacalcet Tablets PAN India Distribution Network
Our distribution spans across major Indian cities including Mumbai, Delhi, Chennai, Bangalore, Hyderabad, and Kolkata. Our logistic capability ensures timely deliveries and consistent product availability for hospitals, clinics, retail pharmacies, and institutional buyers.
Global Reach – Trusted by Healthcare Providers Worldwide
As a top Cinacalcet Tablets exporter from India, Taj Pharmaceuticals partners with distributors, importers, NGOs, hospitals, and tender buyers to deliver superior medicines across Africa, Latin America, the Middle East, and Southeast Asia.
Order Information and Bulk Inquiry
To place bulk orders or inquire about our PCD Pharma Franchise, contact our export division directly at:
- Email: info@tajpharma.com
- Phone: +91-22-2637 9171 / +91-22-2637 9172
- Website: www.tajpharma.com
We provide fast quotations, technical dossiers, and flexible payment terms for eligible partners.















































































































